In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A

Masatoshi Uno, Junjiroh Tsuchiyama, Akiyoshi Moriwaki, Toshio Noguchi, Kazuhiro Mizoguchi, Tetsuya Ogino, Tadashi Yoshino, Shigeru Okada, Mine Harada

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV)-associated nasal T/ natural killer (NK) cell lymphoma has often been reported in Asian countries and has been recently confirmed as a novel clinicopathological entity. The prognosis of advanced stage disease is quite poor and an effective chemotherapeutic modality is strongly advocated. We have established the novel cell line NK-YS, which preserves the original characteristics of EBV-associated nasal angiocentric T/NK cell lymphoma. Using this cell line, we investigated the induction of apoptosis by apoptosis-inducing agents, and expression of P-glycoprotein (P-gp), p53 and bcl-2 proteins. NK-YS showed resistance towards apoptosis-inducing agents and expressed bcl-2 and P-gp but not p53. To overcome this drug resistance, we added cyclosporine A (GSA) and these agents to culture media as a P-gp antagonist. The combination of GsA and etoposide or GsA and doxorubicin induced apoptotic cell death. These results indicated that P-gp-mediated drug resistance is an essential mechanism of drug resistance of the NK-YS cell line. Combined therapy of conventional anti-cancer agents with GsA may have an important place in the establishment of a curative therapy for disseminated nasal angiocentric NK cell lymphoma.

Original languageEnglish
Pages (from-to)1009-1014
Number of pages6
JournalBritish Journal of Haematology
Volume113
Issue number4
DOIs
Publication statusPublished - 2001

Keywords

  • Chemotherapy
  • Cyclosporine A
  • Drug resistance
  • NK cell
  • P-glycoprotein

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A'. Together they form a unique fingerprint.

Cite this